Helén Tuvesson
Chief Executive Officer presso ACTIVE BIOTECH AB
Provenienza dei contatti di primo grado di Helén Tuvesson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 28 | |
21
| Public Company | Biotechnology | 21 |
Active Security Trading AB
2
| Subsidiary | 2 | |
Actinova AB
2
| Subsidiary | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Helén Tuvesson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AEROCRINE AB | Electronic Equipment/Instruments | Founder Chairman | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
Brummer & Partners AB
 Brummer & Partners AB Investment ManagersFinance Brummer & Partners AB is an asset management company that provides a range of managed funds through its managers. The company was founded in 1995 and is headquartered in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| University of Lund | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Nordstjernan AB
 Nordstjernan AB Investment ManagersFinance Nordstjernan AB is a private equity firm founded in 1890 by Axel Johnson. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Director/Board Member Chief Executive Officer | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
PharmaCell BV
 PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | Biotechnology | Director/Board Member | |
Oxyrane UK Ltd.
 Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member General Counsel | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
East Bay AB
 East Bay AB Real Estate DevelopmentFinance East Bay AB through its subsidiaries owns and manages real properties and estate. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman Chairman Chief Executive Officer | |
| LIDDS AB | Pharmaceuticals: Major | Chairman Chairman | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Skane University Hospital
 Skane University Hospital Hospital/Nursing ManagementHealth Services Skane University Hospital operates a search service called Hitta Vård, which provides contact information for public and private healthcare providers in the Skåne region of Sweden. The private company is based in Malmö, Sweden. The service is financed by Region Skåne. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Chief Operating Officer | |
Immedica Pharma AB
 Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Chairman Director/Board Member | |
| ELC Fastigheter | Director/Board Member | ||
| Henvålens Fjällgård AB | Director/Board Member | ||
| Rotterdam School of Management | College/University | Doctorate Degree | |
| Psoriasis+Creams Sweden AB | Director/Board Member Chairman Director/Board Member | ||
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
| Jarna Mejeri AB | Director/Board Member | ||
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| Fylkesjukhuset | Corporate Officer/Principal | ||
| TRANSCODE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ELICERA THERAPEUTICS AB | Biotechnology | Director/Board Member General Counsel | |
| Bioentrepreneur BV | Founder | ||
| SRE Hogfors AB | Chairman |
Statistiche
Distribuzione geografica
| Svezia | 29 |
| Paesi Bassi | 15 |
| Stati Uniti | 4 |
| Regno Unito | 3 |
| Germania | 2 |
Settori
| Health Technology | 24 |
| Finance | 9 |
| Consumer Services | 8 |
| Health Services | 3 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 248 |
| Corporate Officer/Principal | 82 |
| Chairman | 81 |
| Independent Dir/Board Member | 59 |
| Chief Executive Officer | 51 |
Contatti più connessi
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Peter Sjöstrand | 35 |
| Michael Shalmi | 25 |
| Dharminder Singh Chahal | 25 |
| Sven Arne Andréasson | 24 |
| Karl Peter Thelin | 24 |
| Uli Alf Hacksell | 20 |
| Sven Rohmann | 20 |
| Sten Peter Hofvenstam | 19 |
| Kerstin Valinder-Strinnholm | 18 |
| Andrea van Elsas | 16 |
| Peter Jan Sture Ström | 15 |
| Mats Blom | 15 |
| Elaine Sullivan | 15 |
| Erik Esveld | 15 |
- Borsa valori
- Insiders
- Helén Tuvesson
- Connessioni Società
